What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers.
Company
July 5
Weekly Gain
Celldex Therapeutics (NASDAQ: CLDX )
$21.27
36%
Novavax (NASDAQ: NVAX )
$2.62
28%
Zynga (NASDAQ: ZNGA )
$3.45
23%
Glu Mobile (NASDAQ: GLUU )
$2.55
15%
Tesla Motors (NASDAQ: TSLA )
Hot Quality Companies To Own In Right Now: Pacific Ethanol Inc.(PEIX)
Pacific Ethanol, Inc. produces and markets low carbon renewable fuels in the United States. It sells ethanol to gasoline refining and distribution companies; provides ethanol transportation, storage, and delivery services in the Western United States, primarily in California, Arizona, Nevada, Utah, Oregon, Colorado, Idaho, and Washington; and markets ethanol co-products, including wet distiller grains and syrup to dairy operators and animal feed distributors. The company also provides operations, maintenance, and accounting services to a cellulosic integrated bio-refinery in Boardman, Oregon. Pacific Ethanol, Inc. was founded in 2003 and is headquartered in Sacramento, California.
Advisors' Opinion:- [By Tristan R. Brown]
Three months ago I wrote that the stock performance YTD of independent ethanol producer Pacific Ethanol (PEIX) was an "aberration", especially in light of the performance of its industry peers' shares. The discrepancy between Pacific Ethanol's share price and those of its peers has only grown more pronounced since July (see figure). Green Plains Renewable Energy (GPRE) and REX American Resources (REX) have continued to greatly outperform the S&P 500. Even Biofuel Energy, which fell behind on its interest and debt payments over the summer and is facing a shareholder-ruining liquidation, has seen its share price perform significantly better than Pacific Ethanol's in 2013. The oddest part about the stock's performance over the last three months, however, is that the period has been marked by multiple positive announcements from the company. It late July it reported its first positive EPS in almost two years for Q2 (0.07). Its Q2 EBITDA of $3.8 million was its highest since Q4 2011. Its current ratio is well above its previous lows, its ratio of total assets to total liabilities is increasing, and its total shareholders' equity is at a 3-year high. Despite these improvements, the company's price/book ratio is a mere 0.77.
- [By Paul Ausick]
Ethanol producers like Pacific Ethanol Inc. (NASDAQ: PEIX), The Andersons Inc. (NASDAQ: ANDE) and Archer Daniels Midland Co. (NYSE: ADM), as well as other members of the trade group Renewable Fuels Association (RFA), are mightily displeased by this EPA proposal. Refiner and ethanol producer Valero Corp. (NYSE: VLO), which is not a member of the trade group, has been among the loudest critics of the higher blending requirements.
- [By Jake L'Ecuyer]
Energy shares dropped by 0.26 percent in the US market today. Among the sector stocks, Endeavour International (NYSE: END) was down more than 5.6 percent, while Pacific Ethanol (NASDAQ: PEIX) tumbled around 2.2 percent.
- [By Paul Ausick]
Ethanol producers and farmers are the losers and the RFA is steaming mad. The group claims that the ��PA is proposing to place the nation�� renewable energy policy in the hands of the oil companies.��Producers like Archer Daniels Midland Co. (NYSE: ADM), Pacific Ethanol Inc. (NASDAQ: PEIX), and The Andersons Inc. (NASDAQ: ANDE) don�� have an oil refining business to offset the proposed cuts to ethanol volumes.
Top 10 Up And Coming Stocks To Buy Right Now: Chromadex Corp (CDXC)
Chromadex Corporation, incorporated on June 19, 2008, is a provider of research and quality-control products and services to the natural products industry. The Company�� products are used by customers worldwide in the dietary supplement, food and beverage, cosmetic and pharmaceutical industries. The Company together with its subsidiaries supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of potential attributes, and reference materials, related contract services, technical consulting and ingredients. On December 3, 2012, ChromaDex Inc. acquired Spherix Consulting Inc. The Company�� principal subsidiaries include ChromaDex, Inc., Chromadex Analytics, Inc. and Spherix Consulting, Inc (Spherix).
The Company provides its clients in the food, supplement and pharmaceutical industries with solutions to manage potential health and regulatory risks. Its science-based solutions are for both new and existing products that may be subject to product liability and/or exposed to changing scientific standards or public perceptions; literature evaluations, and design and assessment of pre-clinical and clinical safety testing. It specializes in regulatory submissions for food and dietary supplement ingredients. For its clients involved in drug development within the pharmaceutical industry, the Company provides similar services, as well as risk-based strategies, including intellectual property data and compliance gap identification, due diligence assessments and investigational new drug writing.
Products and Services
The Company offers bulk raw materials for inclusion in dietary supplements, food, beverage and cosmetic products. Through its catalog, it supplies a range of products necessary to conduct quality control of raw materials and consumer products. The Company through Chromadex Analytics, provides a range of contract services ranging from routine contract analysis for the production of dietary sup! plements, cosmetics, foods and other natural products to elaborate contract research for clients in these industries. The Company provides a range of consulting services in the areas of regulatory support, new ingredient or product development, risk management and litigation support. With an addition of Spherix, it provides regulatory approval and scientific advisory services.
The Company competes with Sigma-Aldrich, Phytolab, US Pharmacopoeia, Extrasynthese, Covance, Eurofins, and Silliker Canada Co.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Chromadex Corp (OTCMKTS: CDXC) and 22nd Century Group Inc (OTCBB: XXII) are, one way or the other, focused on natural products and have been getting some extra attention lately. Moreover, one of these stocks have been the subject of a disclosed investor awareness campaign. Keeping that in mind, are these two small cap stocks natural winners for investors? Here is a quick look:
Top 10 Up And Coming Stocks To Buy Right Now: Hanesbrands Inc. (HBI)
Hanesbrands Inc., a consumer goods company, engages in the design, manufacture, sourcing, and sale of apparel essentials in the United States and internationally. Its product portfolio includes T-shirts, bras, panties, men?s underwear, kids? underwear, casualwear, activewear, socks, and hosiery. The company offers its products under the brand names of Hanes, Champion, Playtex, Bali, L?eggs, Just My Size, barely there, Wonderbra, Stedman, Outer Banks, Zorba, Rinbros, and Duofold. Hanesbrands also licenses its Champion name for collegiate apparel and footwear. The company sells its products through various distribution channels, which include mass merchants, national chains and department stores, direct to Consumer, and other retail channels, such as embellishers, specialty retailers, and sporting goods stores. As of January 2, 2010, it operated 228 outlet stores. The company is headquartered in Winston-Salem, North Carolina. Hanesbrands Inc. operates independently of Sara L ee Corp. as of September 5, 2006.
Advisors' Opinion:- [By Richard Moroney]
When HanesBrands (HBI) initiated a quarterly dividend in April, the underwear maker said the move reflected its debt-reduction progress, cash-flow growth, and margin-improvement prospects.
Top 10 Up And Coming Stocks To Buy Right Now: Capstead Mortgage Corporation (CMO)
Capstead Mortgage Corporation operates as a self-managed real estate investment trust. It invests in leveraged portfolio of residential mortgage pass-through securities consisting of adjustable-rate mortgage securities issued and guaranteed by government-sponsored enterprises or by an agency of the federal government. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 1985 and is headquartered in Dallas, Texas.
Advisors' Opinion:- [By Rich Duprey]
Agency mortgage real estate investment trust�Capstead Mortgage (NYSE: CMO ) announced this morning�its second-quarter dividend of $0.31�per share, the same rate it paid last quarter.
- [By Zain Zafar]
This is bad by any standard, but what makes it even worse is that Hatteras is known to have a relatively defensive portfolio when compared to its fixed-rate focused peers; at the end of the second quarter, ARMs comprised almost 89% of Hatteras' MBS portfolio. Capstead Mortgage (NYSE: CMO ) , a mortgage REIT that follows a similar strategy of investing in ARMs, reported that its book value per share declined by just 3.8% because of market price movements.
- [By Amanda Alix]
Everyone got stung
The huge drop in share price, along with the unusually heavy trading volume, smacked of investor panic. Adjustable-rate mortgage investors like Capstead (NYSE: CMO ) , which reported earnings on Thursday, also took a dive. Even players in the 30-year mortgage market, such as American Capital Agency (NASDAQ: AGNC ) and Annaly (NYSE: NLY ) got dinged, right along with the ARM crowd.
Top 10 Up And Coming Stocks To Buy Right Now: Theravance Inc.(THRX)
Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines for various therapeutic areas, including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. The company?s key development programs with GlaxoSmithKline (GSK) include the RELOVAIR, a Phase 3 clinical trial program for the treatment of patients with chronic obstructive pulmonary disease (COPD) and/or asthma; the LAMA/LABA program, a Phase 3 COPD program; and the Bifunctional Muscarinic Antagonist-beta2 Agonist (MABA) program, a Phase 2b program for the treatment of COPD, as well as Peripherally Selective Mu-Opioid Receptor Antagonist (P Advisors' Opinion:
- [By Brian Orelli]
Following in the footsteps of Abbott spinning out its drug division into AbbVie (NYSE: ABBV ) , and Pfizer spinning out its animal health division into animal health products into Zoetis, Theravance (NASDAQ: THRX ) is splitting up.
- [By Sean Williams]
Perhaps the most exciting new treatment to hit the market in years was recently approved by the FDA. Developed by GlaxoSmithKline (NYSE: GSK ) and Theravance (NASDAQ: THRX ) , Breo Ellipta is a dry powder drug delivered by inhaler and meant to provide long-term relief of air-flow obstruction and reduce COPD exacerbations. The two companies are collaborating on a handful of potentially revolutionary new COPD treatments that combine Theravance's long-acting beta-2 agonists with Glaxo's long-acting muscarinic antagonists. Its next treatment, Breo Anoro, is currently under review by the FDA.
- [By Jonas Elmerraji]
First up is $4 billion biopharmaceutical firm Theravance (THRX). It's been one heck of a year already for THRX's shareholders. Since the calendar flipped over to January, shares of the firm have rallied more than 75%. But the setup forming in shares points to even higher ground for the final quarter of 2013.
That's because Theravance is currently forming an ascending triangle pattern, a bullish setup that's formed by a horizontal resistance level above shares at $42 and uptrending support to the downside. Basically, as Theravance bounces in between those two technical levels, it's getting squeezed closer and closer to a breakout above that $42 resistance level. When that happens, traders have a buy signal.
Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Ascending triangles and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable. Instead, it all comes down to supply and demand for shares.
That $42 is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.
Don't be early on this trade.
- [By Sean Williams]
Finally, Theravance (NASDAQ: THRX ) made waves after announcing that it would be splitting its business into two separate components: Royalty Management, which will focus on drugs currently in the pipeline in collaboration with GlaxoSmithKline, and Theravance BioPharma, which will continue its line of small-molecule rare disease research. Clearly, this gives investors more visibility of where revenue and profit are coming from, but I think it gives Glaxo even more reason to gobble up the Royalty Management segment because now it doesn't have to buy the remaining pipeline of rare disease research.
Top 10 Up And Coming Stocks To Buy Right Now: Applied Industrial Technologies Inc. (AIT)
Applied Industrial Technologies, Inc. distributes industrial products for maintenance, repair, and operational needs, as well as original equipment manufacturing applications primarily in the United States, Canada, Australia, New Zealand, Mexico, and Puerto Rico. The company offers bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, tools, safety products, and other industrial supplies; and fluid power products, such as hydraulic, pneumatic, lubrication, and filtration components and systems. It also operates regional fabricated rubber shops, which modify and repair conveyor belts and make hose assemblies; and rubber service field crews to install and repair belts and rubber linings at customer locations. In addition, the company assembles fluid power systems and components; performs equipment repair; offers technical advice to customers; and provides maintenance training, and inventory and stor eroom management solutions. It serves various industries, such as agriculture and food processing, automotive, chemical processing, forest products, industrial machinery and equipment, mining, primary metals, transportation, and utilities, as well as to government entities. The company offers industrial products through a network of service centers; and fluid power products directly to customers. Applied Industrial Technologies, Inc. was founded in 1923 and is headquartered in Cleveland, Ohio.
Advisors' Opinion:- [By Marc Bastow]
Industrial components distributor Applied Industrial Technologies (AIT) raised its quarterly dividend 8.7% to 25 cents per share, payable on Feb. 28 to shareholders of record as of Feb. 14.
AIT Dividend Yield: 1.98% - [By Dividends4Life]
Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:
1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number
GWW is trading at a premium to all four valuations above. The stock is trading at a 10.0% premium to its calculated fair value of $219.95. GWW did not earn any Stars in this section.
Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:
1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%
GWW earned three Stars in this section for 1.), 2.) and 3.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. GWW earned a Star for having an acceptable score in at least two of the four Key Metrics measured.
Rolling 4-yr Div. > 15% means that dividends grew on average in excess of 15% for each consecutive 4 year period over the last 10 years (2003-2006, 2004-2007, 2005-2008, etc.) I consider this a key metric since dividends will double every 5 years if they grow by 15%. The company has paid a cash dividend to shareholders every year since 1965 and has increased its dividend payments for 42 consecutive years.
Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked - [By Rich Duprey]
Industrial distributor�Applied Industrial Technologies� (NYSE: AIT ) announced today its third-quarter dividend of $0.23�per share, the same rate it's paid for the past two quarters after raising the payout 9.5% from $0.21 per share.
Top 10 Up And Coming Stocks To Buy Right Now: Shutterstock Inc (SSTK)
Shutterstock, Inc. (Shutterstock) operates as a marketplace for commercial digital imagery. Commercial digital imagery consists of licensed photographs, illustrations and videos that companies use in their visual communications, such as Websites, digital and print marketing materials, corporate communications, books, publications and video content. As of April 30, 2012, Shutterstock's image library contained more than 19 million images. It operates in North America, Europe and Rest of the world. The Company offers a range of content types, including photography, illustrations, vector art and video footage. Shutterstock�� brands include Shutterstock and Bigstock. Its online marketplace provides a freely searchable library of commercial digital images that its users can pay to license, download and incorporate into their work. Users can search its library and preview watermarked versions of its content. In November 2011, Shutterstock launched Shutterstock for iPad, an application enabling visitors to search, browse and organize images using an iPad.
The Company�� products consist of Photographs, Illustrations and Vector Art, and Video Footage. The Company offers photographs that cover a range of subjects, including animals/wildlife, the arts, backgrounds/textures, beauty/fashion, buildings/landmarks, business/finance, celebrities, education, food and drink, healthcare/medical, holidays, nature, objects, people, religion, science, sports/recreation, technology and transportation. Its photography collection is made up of images that can be used in both commercial and editorial contexts. Images that are marked as editorial-only, such as photographs of celebrities and newsworthy events, which constitute fewer than 5% of its total images, cannot be used to promote a product or service; instead these images are licensed for use in editorial settings, such as newspapers, blogs and magazines. Photographs are available in a range of sizes, including small files that are appropriate for mobile b! rowsing and large files appropriate for large format prints and high-resolution displays. As of December 31, 2011, photographs made up 69% of its library.
In addition to photographic images, the Company also offers images that have been created using illustration tools and software. These images are made up of two types: illustrations (raster graphics) and vector art (vector graphics). Raster graphics are stored as a fixed set of pixels, whereas vector graphics are stored using geometric modeling. As of December 31, 2011, illustrations an vector art made up 28% of its library. For users engaged in producing video advertisements, commercial motion pictures, television programming, video games, interactive applications and other video-based media, it also provides video footage. Footage clips are available in a range of formats and sizes, including high definition (HD). As of December 31, 2011, its video footage library contained more than 400,000 video clips and made up 3% of its library.
The Company competes with iStockphoto, Fotolia, Dreamstime, Getty Images, Corbis Corporation, Reuters Group PLC, the Associated Press, Thought Equity Motion, Facebook and Flickr.
Advisors' Opinion:- [By Sean Williams]
Commercial digital image library Shutterstock (NYSE: SSTK ) looked picture-perfect today with an 18.9% gain after the company announced better-than-expected fourth-quarter results, and an optimistic full-year forecast after the closing bell last night. For the fourth quarter, Shutterstock delivered revenue growth of 38%, to $68 million, as the number of paid downloads increased 31%, to 28 million, and the number of images in its collection vaulted higher by 8.9 million, to 32.2 million. Net income, however, fell by roughly three-quarters, to just $7.9 million, or $0.26 per share in adjusted EPS. Comparatively, Wall Street had only expected Shutterstock to report a $0.21 EPS profit on $65.8 million in revenue. Looking ahead, Shutterstock anticipates full-year revenue will be in the range of $305 million-$310 million, which is modestly higher than the current consensus of $304.5 million. There's little denying that Shutterstock is gaining online acclaim, but at 70 times forward earnings, I'd consider passing on the stock here.
- [By Paul Ausick]
But the real news is the near vertical trajectory in share prices for the two stocks. This could be another manifestation of the market�� hunger for some momentum plays, as we noted earlier this morning the bump to share prices for both JinkoSolar Holding Co. Ltd. (NYSE: JKS) and Shutterstock Inc. (NASDAQ: SSTK), both of which held secondary share sales this morning.
No comments:
Post a Comment